Statins in the elderly: a patient-focused approach

Area of Science:

• Gerontology
• Cardiovascular Medicine
• Pharmacology

Background:

• Individuals over 65 represent the fastest-growing US population and possess the highest cardiovascular risk.
• Paradoxically, cardiovascular treatment intensity in the elderly is inversely related to baseline risk.
• Current guidelines recommend moderate-intensity statin therapy for secondary prevention in those over 75 due to limited evidence for high-intensity use.

Purpose of the Study:

• To examine the current landscape of statin therapy in elderly individuals.
• To highlight the discrepancy between cardiovascular risk and treatment intensity in older adults.
• To emphasize the need for a balanced approach when considering statin initiation and continuation in the elderly.

Main Methods:

• Review of current guidelines and evidence regarding statin use in individuals aged 65 and older.
• Analysis of the inverse relationship between baseline cardiovascular risk and treatment intensity in this demographic.
• Discussion of the benefits and risks associated with statin therapy in the elderly population.

Main Results:

• Despite evidence of statin benefits in the elderly, treatment intensity is often lower than anticipated based on risk.
• Limited randomized controlled trial data exists for high-intensity statin therapy in individuals over 75.
• A significant gap exists between the potential benefits of statins and their actual utilization in older adults.

Conclusions:

• The decision to initiate or continue statin therapy in the elderly requires careful consideration of both benefits and risks.
• Potential benefits include secondary atherosclerotic cardiovascular prevention, stroke reduction, and decreased morbidity/mortality.
• Potential risks include altered metabolism, comorbidities, polypharmacy, drug interactions, side effects, cognitive issues, and cost.